000 01219 a2200349 4500
005 20250514055141.0
264 0 _c20030327
008 200303s 0 0 eng d
022 _a1469-493X
024 7 _a10.1002/14651858.CD003351
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBell, R
245 0 0 _aKetamine as an adjuvant to opioids for cancer pain.
_h[electronic resource]
260 _bThe Cochrane database of systematic reviews
_c2003
300 _aCD003351 p.
_bdigital
500 _aPublication Type: Journal Article; Review; Systematic Review
650 0 4 _aAdult
650 0 4 _aAnalgesics
_xadverse effects
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aHallucinations
_xchemically induced
650 0 4 _aHumans
650 0 4 _aKetamine
_xadverse effects
650 0 4 _aMorphine
_xadverse effects
650 0 4 _aNeoplasms
_xcomplications
650 0 4 _aPain
_xdrug therapy
650 0 4 _aPalliative Care
650 0 4 _aRandomized Controlled Trials as Topic
700 1 _aEccleston, C
700 1 _aKalso, E
773 0 _tThe Cochrane database of systematic reviews
_gno. 1
_gp. CD003351
856 4 0 _uhttps://doi.org/10.1002/14651858.CD003351
_zAvailable from publisher's website
999 _c12337421
_d12337421